Replies to post #20751 on Biotech Values

[Praveen]

ELAN, Hi ioio

Nope... I don't have any experience on the advisory committee. However I am with you on about a possible "no-Advisory-Committee" suprise.Any ideas from YMB? But because this is dec, many institutions and traders may sell eln for a tax loss as a window dressing. So I am thinking if to sell a part of my position(33%) and reenter in Jan or if that would be a costly mistake.

Biogen says there will be an FDA panel on Tysabri in March. The FDA Advisory Panel on Peripheral and Central Nervous System Drugs meets March 7 and 8.

Take care,
Praveen